Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1381 results found. Search for [ pharmaceutical company ]

Results 1 to 21 of 1381
PB Jayakumar
December 12, 2019
Mainly targeted at MSMEs that face cash crunch for expansion and working capital requirements, the firm claims to offer loans at lesser rates of interest compared to other NBFCs with small ticket size loans under business loans, personal loan, professional loan and consumer durable loans


E Kumar Sharma
New Delhi, December 11, 2019
At a time when most pharma companies are cash-strapped, Divis has undertaken big capex with its cash surplus


Joe C Mathew
New Delhi, December 10, 2019
According to AIDAN, the agreements the company has drawn up with doctors in the guise of consultancy are not only illegitimate and unethical, but also undermine the medical practitioner's autonomy and professional integrity


BusinessToday.In
December 3, 2019
Ogivri will be launched at a competitive discount for customers to help ensure increased access to treatment for thousands of HER2-positive breast and gastric cancer patients, said Biocon


E Kumar Sharma
December 2, 2019
Earlier this month, AstraZeneca announced three large-scale initiatives to build on the company's long-standing commitment to China and advance global R&D for innovative new medicines


PB Jayakumar
November 26, 2019
TSSIA is meeting tomorrow to decide the future course of action, which includes a meeting of all Gramapanchayath heads and other authorities and the possibility of legal remedies: Ninad Jaywant


E Kumar Sharma
New Delhi, November 25, 2019
Rajiv Malik, President, Mylan, speaks about the impact the deal will have on India operations, the challenges in generic drugs and the role that China will play


BusinessToday.In
November 25, 2019
Snapping three-days losing streak, the share price of Unichem Laboratories opened higher, rising 7.4% to touch the day's high of Rs 164 apiece on the BSE


BusinessToday.In
November 21, 2019
Ministry of Commerce (MOFCOM), People's Republic of China announced that starting Thursday, the anti-dumping duties on pyridine imports from  India and Japan will be withdrawn


PTI
November 18, 2019
The significant violations included failure to have adequate written procedures for the receipt, identification, testing and handling of raw materials


PB Jayakumar
New Delhi, November 12, 2019
The divestment will curtail 13 per cent global revenues of Lupin, which had posted Rs 16,369 crore consolidated revenues for the financial year ended March 31, 2019


BusinessToday.In
New Delhi, November 12, 2019
The deal proceeds will be utilised to strengthen Lupin's balance sheet as well as provide growth capital to support organic and inorganic initiatives for our focus markets, says Lupin CEO Vinita Gupta


PTI
November 8, 2019



BusinessToday.In
New Delhi, November 7, 2019
Sun Pharma Q2 results: India sales, which accounted for 31.6 per cent of total consolidated sales, rose 35 per cent year-on-year (YoY) to Rs 2,515 crore in September quarter of this fiscal


BusinessToday.In
November 7, 2019
Sun Pharma Q2 result today: The drug major's share price was trading higher ahead of the firm's Q2 earnings


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


BusinessToday.In
November 6, 2019
AstraZeneca Pharma will sell Sun Pharma's cancer treatment drugs in China.\"The agreement will help to bring cost-effective and quality drugs to patients in China,\" the regulatory filing said.


PB Jayakumar
November 6, 2019
Most violations relate to rectifiable documentation, data maintenance, batch-wise consistent production quality, data on supply chain, stability issues, microbial contamination and quality checks


BusinessToday.In
New Delhi, November 4, 2019
SPARC Q2 results: Total income declined sharply by 70.49 per cent to Rs 19.45 crore during the second quarter as compared with Rs 65.92 crore in the year-ago period


BusinessToday.In
November 4, 2019
Hikal share price gained up to 9.51% to Rs 131.90 compared to the previous close of Rs 120.45 on BSE


PAGES 1 OF 70  12345